EGFR and central nervous system cancer: Thus, glioma cells with aberrant expression of EGFR have been shown preference for stiffer microenvironments (Sivakumar et al., 2017), and softness of the glioma tissue positively correlated with higher tumor grade and IDH1 mutation (Pepin et al., 2018).